China's Yingke Biopharmaceutical bags $42.4m in Series B round

China's Yingke Biopharmaceutical bags $42.4m in Series B round

Photo from Yingke Biopharmaceutical's official WeChat account.

02 June, 2023

Edited by: Paramita Chatterjee

China Life Insurance

Printed by Unregistered user on Sat, 12 Jul 2025 05:18:31 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

China’s healthcare deals struggle, but M&As expected to drive growth

People Digest: Keppel DC REIT gets new CEO; BDA ropes in China healthcare head

Read more from Greater China

Policy & Regulations

Shanghai to consider policy responses to stablecoins, cryptocurrencies

Policy & Regulations

China’s Chery, BYD may have to repay subsidies after audit finds improper claims